The Role of the Hospital Dermatologist in the Diagnosis and Treatment of Calciphylaxis and Nephrogenic Systemic Fibrosis

Seminars in Cutaneous Medicine and Surgery

Volumn 26, Issue 3, 2007, Pages 163-167

  Weenig, Roger H ^a   Gibson, Lawrence E ^a   el Azhary, Rokea ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

calciphylaxis; nephrogenic fibrosing dermopathy; sclerosis; tissue plasminogen activator; wound care

Indexed keywords

HYDROXYCHLOROQUINE; SODIUM THIOSULFATE; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ADULT; AGED; CALCINOSIS; CASE REPORT; CLINICAL EXAMINATION; CLINICAL PRACTICE; CORRELATION ANALYSIS; DIAGNOSTIC APPROACH ROUTE; DIALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYPERBARIC OXYGEN; HYPERPARATHYROIDISM; KIDNEY DYSFUNCTION; LOW DRUG DOSE; MALE; MORBIDITY; MORTALITY; NEPHROGENIC FIBROSING DERMOPATHY; PARATHYROIDECTOMY; PHOTOTHERAPY; REVIEW; SKIN BIOPSY; SKIN MANIFESTATION; TREATMENT OUTCOME; WOUND CARE;

AGED; CALCIPHYLAXIS; DERMATOLOGY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROSIS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHYSICIAN'S ROLE; SKIN; SKIN DISEASES; WOUND HEALING;

EID: 36749012326     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2007.09.003     Document Type: Review

References (20)

1. Cowper S.E., Robin H.S., Steinberg S.M., et al. Scleromyxedema-like cutaneous diseases in renal-dialysis patients. Lancet 356 (2000) 1000-1001
2. Klein K.L., and Pittelkow M.R. Tissue plasminogen activator for treatment of livedoid vasculitis. Mayo Clin Proc 67 (1992) 923-933
3. Sewell L.D., Weenig R.H., Davis M.D.P., et al. Low-dose tissue plasminogen activator for calciphylaxis. Arch Dermatol 40 (2004) 1045-1048
4. Monney P., Nguyen Q., Perroud H., et al. Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure. Nephrol Dial Transplant 19 (2004) 2130-2132
5. Velasco N., MacGregor M.S., Innes A., et al. Successful treatment of calciphylaxis with cinacalcet-an alternative to parathyroidectomy?. Nephrol Dialysis Transplant 21 (2006) 1999-2004
6. Cicone J.S., Petronis J.B., Embert C.D., et al. Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis 43 (2004) 1104-1108
7. Tittelbach J., Graefe T., and Wollina U. Painful ulcers in calciphylaxis-combined treatment with maggot therapy and oral pentoxyfylline. J Dermatol Treat 12 (2001) 211-214
8. Weenig R.H., Sewell L.D., Davis M.D., et al. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol 56 (2007) 569-579
9. Kang A.S., McCarthy J.T., Rowland C., et al. Is calciphylaxis best treated surgically or medically?. Surgery 128 (2000) 967-972
10. Cowper S.E., Robin H.S., Steinberg S.M., et al. Scleromyxedema-like cutaneous diseases in renal-dialysis patients. Lancet 356 (2000) 1000-1001
11. Cowper S.E., Su L.D., Bhawan J., et al. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 23 (2001) 383-393
12. Ting W.W., Stone M.S., Madison K.C., et al. Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 139 (2003) 903-906
13. Marckmann P., Skov L., Rossen K., et al. Nephrogenic systemic fibrosis: Suspected etiologic role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17 (2006) 2359-2362
14. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol Dial Transplant 21 (2006) 1104-1108
15. Food and Drug Administration: http://www.fda.gov/cder/drug/infopage/gcca/defautl.htm
16. Steen H, Schwenger V: Good MRI images: To Gad or not to Gad? Pediatr Nephrol
17. Leung N., Swaminathan S., Ahmed I., et al. Erythropoietin, gadolinium, and nephrogenic fibrosing dermopathy-response. (letter). Ann Intern Med 146 (2007) 230
18. Swaminathan S., Ahmed I., McCarthy J.T., et al. Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy. Ann Intern Med 145 (2006) 234-235
19. Mendoza F.A., Artlett C.M., Sandorfi N., et al. Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature. Semin Athritis Rheum 35 (2006) 238-249
20. Cowper S.E., and Boyer P.J. Nephrogenic systemic fibrosis: An update. Curr Rheumatol Rep 8 (2006) 151-157